India’s pharma sector is turning crisis into reform. The Coldrif tragedy exposed gaps, but also drove unprecedented action across states and regulators. A new chapter in drug safety is being written, fast.
Wednesday, February 4
Trending
- Where Science Meets Justice: School of Sciences, JAIN (Deemed-to-be University), Redefines Forensic Education with ISACA-Certified Excellence
- “Union Budget 2026-27 Progressive and Growth-Oriented” – Chairman, MATEXIL
- Mastering Gold Trading with an XAU USD Pip Calculator
- Sleep Trends 2026: What Indian Consumers Want in Their Mattress
- Leading IVF Center in Nagpur: Aansh Hospital and IVF Center by Dr. Shweta Agarwal
- Brandman Retail Limited IPO Opens on February 4, 2026
- Patel Retail Limited Delivers Strong Q3 FY26 Performance with 36 percent Revenue Growth & 96 percent Surge in Profit
- SoupX launches ‘SoupX – Sip of Health’ outlet at Gurugram hospital
